Nicotinamide mononucleotide (NMN) is a promising anti-aging molecule that may slow down the aging process and improve cellular health. It is available in various food sources, including broccoli and cabbage. However, more studies are needed before this product can be considered safe and effective for humans.

NMN is a natural molecule that is present in all living organisms. It is an intermediate in the biosynthesis of NAD+, a metabolic product that provides energy for cells. The body loses its NAD+ level as it ages. NMN reverses this process by stimulating the production of NAD+.

NMN has been reported to exhibit therapeutic effects in many age-related diseases. Researchers are conducting clinical trials to confirm its effects in humans. A clinical trial is currently underway at the Keio University School of Medicine in Japan.

NMN is an important component of the nicotinamide phosphoribosyltransferase (NAMPT), a biosynthetic pathway of NAD+ in mammalian cells. When NMN is given orally, it is rapidly absorbed and produces NAD+ in peripheral tissues within 15 minutes.

In addition to its therapeutic effect, NMN has also been shown to be a protective factor against aging. Research has demonstrated that NMN is beneficial in reducing the risk of a variety of age-related conditions, including cardiovascular disease, diabetes, and obesity.

NMN has been shown to be effective in repairing DNA damage. Chronic inflammation accelerates the degradation of NAD+. This damage can also cause age-related cognitive decline.

NMN has also been shown to enhance heart function and glucose tolerance. In addition, studies have shown that NMN can ameliorate the symptoms of a variety of age-related conditions, such as Alzheimer’s disease, dementia, and cardiac ischemia.